Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Problem 2. Pfizer is deciding how to price a new patented drug in two different markets. In the first market, consumers are relatively rich,

image text in transcribedimage text in transcribed

Problem 2. Pfizer is deciding how to price a new patented drug in two different markets. In the first market, consumers are relatively rich, and the demand for this drug is QR-50-p. In the second market, consumers are relatively poor, and the demand is Qp=10-p. Suppose that the marginal cost of producing the drug is zero and the fixed cost is 100. a) Suppose that Pfizer can charge different prices in each country (3rd Degree Price Discrimination). What price should it charge in each country? How many drugs would it sell in each? b) What is the combined deadweight loss from monopoly power in both markets in the previous case? Now suppose that Pfizer is not allowed to charge different prices in these two markets. Therefore, consumers in both rich and poor markets now become a single market. c) Write down the total quantity demanded in this market for prices below 10 (as a function of the price p). Write down the total quantity demanded in this market for prices between 10 and 50 (as a function of p). Draw this total demand function graphically. (Hint: Remember that people can't buy negative quantities. For which price, would the demand of each group fall below zero?) d) Using the demand above when prices are less than 10, calculate the optimal price that Pfizer should charge. For this price, how much do consumers in each market buy? e) Based on your previous answer, what price should Pfizer charge? What is the deadweight loss in this case? f) In the case considered here, who benefits and who is hurt by allowing Pfizer to price discriminate? g) Now suppose that, instead, the demand in the poor country is Qp=30-p. Demand in the rich country remains the same as above. Calculate the new equilibrium prices with and without price discrimination. h) In (g), who benefits and who is hurt but by allowing Pfizer to price discriminate? i) Explain the difference between you answers in (f) and (h). Which case do you think is more common in practice? (This is an open-ended question, meant to make you summarize the conceptual conclusion from the algebraic exercise.)

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Managerial Economics and Business Strategy

Authors: Michael R. baye

7th Edition

978-0073375960, 71267441, 73375969, 978-0071267441

More Books

Students also viewed these Economics questions